Login / Signup

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO).

David PasquierPhilippe NickersDidier PeiffertPhilippe MaingonPascal PommierThomas LacornerieGeoffrey MartinageEmmanuelle TreschEric Lartigau
Published in: PloS one (2017)
ClinicalTrials.gov NCT01596816.
Keyphrases
  • prostate cancer
  • brain metastases
  • radiation therapy
  • benign prostatic hyperplasia
  • anti inflammatory
  • open label
  • randomized controlled trial